2026-10-25
Teledyne Technologies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 26,946 −5.25%
S&P 7,428 −3.39%
GOLD $4,132 +1.46%
BTC $75,633 −5.94%
VIX 23.84 +43.53%
latest tape · as of 18:03 UTC
The Screen · Technology · Scientific & Technical Instruments
Teledyne Technologies
TDY · a US exchange · USD · Market cap $30.5B · 15,800 employees
Teledyne Technologies Incorporated provides enabling technologies for industrial growth markets in the United States, Europe, Asia, and internationally.
Not yet scored632.01 USD
Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 18:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price632.01 USD at the 4 Nov 2026 close
- Our value readUndervalued vs our fair value, as of 4 Nov 2026
- Our regime readMarkup, as of 4 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 1.63)
- Last reviewed4 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $581.40 to $898.70, base estimate $748.23 (screen dated 2026-11-04).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning political selling, disclosed 2026-09-25
- Options put/call open interest 1.63, read 2026-11-05
- Ethical screen not yet scored
Price632.01 USD
Fair value748.23
Ethical score91.3/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-11-04Read Markup663.63-4.8% to today Accumulation gives way to Markup after a 9% rise in 3 weeks
2026-10-11Read Accumulation610.83+3.5% to today ✓Markdown gives way to Accumulation
2026-09-14Read Markdown595.23+6.2% to today Accumulation gives way to Markdown after a 13% slide in 4 weeks
2026-08-14Read Accumulation683.73-7.6% to today Distribution gives way to Accumulation after a 14% rise in 6 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markup label.
Teledyne Technologies holds its Markup at $632.01. Consolidating, no directional conviction, held for 73 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 73 days |
| Price at the screen | $632.01 |
| Valuation | 30.14 trailing · 23.80 forward price to earnings |
| Values screen | Not scored · score 91.3 |
| Beta | 0.90 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 17.29% | Below 33% | Interest-bearing debt is just 17.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 8.80% | Below 49% | Money owed to the company is 8.8% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Teledyne Technologies clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Teledyne Technologies clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 17%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
The Conscience Overlay What do these labels mean?
Conscience flag · AFSC Investigate
What the Numbers Say It Is Worth
The quantitative screen above is arithmetic. Separately, community boycott lists cite this company: Documented on AFSC Investigate. The desk records that flag here without folding it into the verdict: the screen measures the balance sheet, the overlay informs the conscience, and they are different judgements that belong to different owners. The second one is yours.
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly an 11% discount to our $748.23 fair value, narrow competitive moat, 9.40% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 15.5% discount to the base estimate.
Third-party analyst targets: 12 covering, consensus Buy. The average target sits +23% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere our models see it going: fair-value estimate $748.23, with a range of $581.40 to $898.70, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsSensors Powering Industry Face a Steep Price
Picture the infrared cameras and digital sensors quietly enabling factory automation and medical imaging across continents. Teledyne delivers those enabling technologies with steady 8% revenue growth and a clean ethical screen, yet the shares sit at 24.4 times forward earnings while the opportunity rating flags them overvalued against a narrow moat and modest 9% return on equity.
That combination leaves little room for error. Profit margins of 15% look respectable, but the low return on capital and limited competitive edge suggest the business may struggle to compound value faster than the current price already assumes.
Analyst targets cluster near 750, yet history shows narrow-moat industrial suppliers often trade down when growth slows or cycles turn. The 12% gap to stated fair value does not change the overvalued verdict at these multiples.
Analysis, not advice.
| Forward P/E | 23.8xexpensive even after accounting for its growth |
| Trailing P/E | 30.1xa premium valuation |
| EPS, trailing | 21.84 |
| EPS, forward | 27.65 |
| Revenue growth | +9.4%steady growth |
| Profit margin | 15.8%healthy profit margins |
| Return on equity | 9.5%a modest return on shareholder capital |
| FCF yield | 3.13% |
| Debt to equity | 0.18minimal debt: a conservative balance sheet |
| Current ratio | 2.31comfortably covers its short-term bills |
| Beta | 0.90steadier than the market |
| Short interest, float | 0.03% |
| 52-week range | 483.02 - 697.67 |
| Moat | NARROW |
| Market cap | $30.5B |
| Employees | 15,800 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Titan Case StudyOur full written analysis of TDY: TDY Case Study → 2026-07-02
Where & How to TradeTDY trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-04
Markup · changed $663.63
+7.3% Entry 17
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.3% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729.
2026-10-28
Accumulation $618.60
+0.0% Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729.
2026-10-21
Accumulation $618.60
+0.0% Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20
Accumulation $618.60
+0.0% Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19
Accumulation $618.60
+0.0% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18
Accumulation $618.60
+0.0% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-17
Accumulation $618.60
-0.2% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.2% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-16
Accumulation $619.91
+1.0% Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-15
Accumulation $613.66
+0.0% Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-14
Accumulation $613.66
+0.5% Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.5% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (13 analysts) rates it buy, with a mean price target of $729. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- What Did It Take To Hold Novanta Stock? Yahoo Finance · 5d ago
- Varex Imaging Shareholders Approve Teledyne Merger Agreement Yahoo Finance · 8d ago
- Unmanned Surface Vehicle (USV) - Global Strategic Business Report: Capitalize on 15.4% CAGR to US$2.2 Billion by 2032 as Textron, Elbit Systems, Teledyne Technologies and Liquid Robotics Accelerate Yahoo Finance · 8d ago
- Teledyne FLIR Defense Wins $48M Contract to Provide Next-Gen Nuclear, Biological and Chemical Reconnaissance Sensors for Bulgaria Strykers Yahoo Finance · 10d ago
- How Rare Is Keysight's Record Sales Growth? Yahoo Finance · 13d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-22 | VANWEES JASON | Officer | 126 | · | |
| 2026-04-22 | KUMBIER MICHELLE A | Director | 319 | · | |
| 2026-04-22 | MORALES VINCENT J | Director | 319 | · | |
| 2026-04-22 | SHERBURNE JANE CECILE | Director | 319 | · | |
| 2026-04-22 | BLACK LAURA A | Director | 319 | · | |
| 2026-04-22 | LORNE SIMON M | Director | 319 | · | |
| 2026-04-22 | VON SCHACK WESLEY W | Director | 319 | · | |
| 2026-04-22 | MALONE ROBERT A | Director | 319 | · | |
| 2026-04-22 | SMITH MICHAEL T. | Director | 319 | · | |
| 2026-02-03 | VANWEES JASON | Officer | 7,500 | $4,730,783 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-25 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 15K–50K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 15K–50K |
| 2026-08-25 | April McClain Delaney | Democrat | sell | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $632.58 | -4.9% | · | $951 | -4.9% |
| 2 months | $645.74 | -6.8% | · | $932 | -6.8% |
| 3 months | $646.57 | -7.0% | · | $931 | -7.0% |
| 6 months | $523.11 | +15.0% | · | $1,150 | +15.0% |
| 1 year | $500.56 | +20.2% | · | $1,202 | +20.2% |
| 2 years | $389.08 | +54.6% | · | $1,546 | +54.6% |
| 3 years | $391.99 | +53.5% | · | $1,535 | +53.5% |
| 5 years | $424.08 | +41.9% | · | $1,419 | +41.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever TDY does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.